Growth Metrics

Mesoblast (MESO) Interest Expenses (2015 - 2025)

Mesoblast recorded quarterly Interest Expenses of $10.8 million in Q2 2025, up 4.56% quarter-over-quarter from $10.3 million in Q2 2024, and up 4.56% year-over-year from $10.3 million in Q2 2024.

Mesoblast's Interest Expenses history runs 11 years deep, the most recent figure standing at $10.8 million for Q2 2025.

  • In Q2 2025, Interest Expenses rose 4.56% year-over-year to $10.8 million; the TTM figure through Dec 2025 stood at $21.1 million (changed 0.5% YoY), while the FY2025 annual figure was $23.0 million, changed 0.18% from the prior year.
  • Interest Expenses came in at $10.8 million for Q2 2025 at Mesoblast, up from $10.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $15.7 million in Q1 2023 to a low of -$4.9 million in Q4 2022.
  • A 5-year average of $4.8 million and a median of $6.1 million in 2021 frame the typical range for Interest Expenses.
  • On a YoY basis, Interest Expenses climbed as much as 2323.82% in 2021 and fell as far as 179.14% in 2021.
  • Mesoblast's Interest Expenses stood at -$4.1 million in 2021, then declined by 20.7% to -$4.9 million in 2022, then surged by 317.88% to $10.7 million in 2023, then fell by 3.43% to $10.3 million in 2024, then advanced by 4.56% to $10.8 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods registered $10.8 million, $10.3 million, and $10.7 million for Q2 2025, Q2 2024, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 22,854.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -5.50 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 61,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -332,000.00
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 12.90 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 69.29 Mn
10 Mesoblast 23.40 Bn 23.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 10.79 Mn
Jun 30, 2025 10.79 Mn
Jun 30, 2024 10.32 Mn
Jun 30, 2024 10.32 Mn
Jun 30, 2023 10.69 Mn
Jun 30, 2023 10.69 Mn
Mar 31, 2023 15.67 Mn
Mar 31, 2023 15.67 Mn
Dec 31, 2022 -4.90 Mn
Dec 31, 2022 -4.90 Mn
Sep 30, 2022 4.55 Mn
Sep 30, 2022 4.55 Mn
Jun 30, 2022 12.94 Mn
Jun 30, 2022 12.94 Mn
Mar 31, 2022 -4.30 Mn
Mar 31, 2022 -4.30 Mn
Dec 31, 2021 -4.06 Mn
Dec 31, 2021 -4.06 Mn
Sep 30, 2021 -4.14 Mn
Sep 30, 2021 -4.14 Mn
Jun 30, 2021 2.53 Mn
Jun 30, 2021 2.53 Mn
Mar 31, 2021 7.73 Mn
Mar 31, 2021 7.73 Mn
Dec 31, 2020 5.13 Mn
Dec 31, 2020 5.13 Mn
Sep 30, 2020 -2.90 Mn
Sep 30, 2020 -2.90 Mn
Jun 30, 2020 6.76 Mn
Jun 30, 2020 6.76 Mn
Mar 31, 2020 319,000.00
Mar 31, 2020 319,000.00
Dec 31, 2019 4.34 Mn
Dec 31, 2019 4.34 Mn
Sep 30, 2019 -3.58 Mn
Sep 30, 2019 -3.58 Mn
Jun 30, 2019 5.21 Mn
Jun 30, 2019 5.21 Mn
Mar 31, 2019 5.21 Mn
Mar 31, 2019 5.21 Mn
Dec 31, 2018 3.33 Mn
Dec 31, 2018 3.33 Mn
Sep 30, 2018 -2.65 Mn
Sep 30, 2018 -2.65 Mn
Jun 30, 2018 -1.41 Mn
Jun 30, 2018 -1.41 Mn
Mar 31, 2018 -423,000.00
Mar 31, 2018 -423,000.00
Mar 31, 2017 -1.26 Mn
Mar 31, 2017 -1.26 Mn
Dec 31, 2016 1.41 Mn
Dec 31, 2016 1.41 Mn
Sep 30, 2016 1.39 Mn
Sep 30, 2016 1.39 Mn
Mar 31, 2016 -2.49 Mn
Mar 31, 2016 -2.49 Mn
Dec 31, 2015 -2.03 Mn
Dec 31, 2015 -2.03 Mn